Dr. Reddy's recalls 1,728 bottles of Rivastigmine Tartrate capsules from US

14 Apr 2017 Evaluate

Dr. Reddy’s Laboratories is recalling 1,728 bottles of Rivastigmine Tartrate capsules, used for treatment of dementia, due to cross-contamination with other products from the US market. The company's US arm, Dr. Reddy’s Laboratories Inc is recalling Rivastigmine Tartrate capsules 1.5 mg in 60-count bottle manufactured by Dr. Reddy’s Laboratories in India.

As per the United States Food and Drug Administration (USFDA), a class III recall is initiated in a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1270.20 4.25 (0.34%)
31-Dec-2025 13:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1270.20
Cipla 1505.70
Zydus Lifesciences 913.05
Lupin 2109.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×